Product Information
FENOFIBRATE 54 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0733 per EA under NDC 59651057590. Its NADAC has been published 161 times since Sep 6, 2023.
FDA first approved this application on Sep 27, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
54 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651057590
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA216798FDA Approved
9/27/2022
TE Code
AB
On Market Since
9/27/2022
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 54 MG TABLET has been published 161 times since Sep 6, 2023, and over the history we have for it it has declined 24.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0733 per EA |
|---|---|
| All-time high | $0.1059 (Feb 14, 2024) |
| All-time low | $0.0561 (Dec 17, 2025) |
| 52-week high | $0.0900 |
| 52-week low | $0.0561 |
| Median price | $0.0806 |
| Average price | $0.0808 |
| Largest weekly change | -27.7% (Nov 20, 2024) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fenofibrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 54 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 54 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0733 per EA (NDC 59651057590), effective Sep 30, 2026.
How has the price of FENOFIBRATE 54 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 54 MG TABLET has declined 24.8%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 54 MG TABLET?
Since Sep 6, 2023, the NADAC for FENOFIBRATE 54 MG TABLET has ranged from a low of $0.0561 (Dec 17, 2025) to a high of $0.1059 (Feb 14, 2024), with a median of $0.0806 per EA.
Are there cheaper alternatives to FENOFIBRATE 54 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 54 MG TABLET, is $0.0630 per EA — about 14% below FENOFIBRATE 54 MG TABLET.
Who manufactures FENOFIBRATE 54 MG TABLET?
FENOFIBRATE 54 MG TABLET (NDC 59651057590) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.